Tacrolimus versus hydrocortisone in management of atopic dermatitis in children, a randomized controlled double‐blind study: New insights on TARC, CTACK, TSLP, and E‐selectin
Immunity, Inflammation and Disease · 2024
DOI: 10.1002/iid3.70028 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Immunity, Inflammation and Disease, 2024. Verfasst von Ammena Y Binsaleh und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy Practice, College of Pharmacy, Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia. Hauptthemen laut MEDLINE: Dermatitis, Atopic, Hydrocortisone, Tacrolimus. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: None.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Introduction
Atopic dermatitis (AD) is a type of chronic inflammatory disorder that affects all age groups including children. AD is characterized by elevated inflammatory marker levels.
Aim
To assess the safety and effectiveness of topical tacrolimus ointment versus topical hydrocortisone cream in the treatment of pediatric AD by comparing the two treatments' ability to reduce serum cytokines. Patients and Methods One hundred AD patients who fulfilled the eligibility criteria completed this clinical study. Two groups of 50 AD patients each were selected from Tanta University's Dermatology Department., Group 1 (the hydrocortisone group) was administered topical hydrocortisone cream for a duration of 4 months. For 4 months, Group 2 was administered tacrolimus topically. Serum levels of thymus and activation regulated chemokine (TARC), cutaneous T cell attractant chemokine (CTAC), interleukin‐10 (IL‐10), interleukin‐6 (IL‐6), E selectin (E‐selectin), and thymic stromal lymphopoietin (TSLP) were measured during an evaluation of the patients by a dermatologist at the beginning and 4 months after the treatment had been started. Children's Dermatology Life Quality Index was used to assess quality of life in these patients.
Results
With the exception of E‐selectin, IL‐6, and IL‐10 ( p > .05), the tacrolimus group had a significant reduction in TARC, CTACK, TSLP ( p < .05) when compared to its baseline and when compared to the hydrocortisone group. Both groups showed a significant improvement in quality of life but no significant changes between groups were observed.
Conclusion
In children with AD, tacrolimus reduces inflammatory biomarkers better than hydrocortisone.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy Practice, College of Pharmacy, Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia.
- Department of Clinical Pharmacy, Faculty of Pharmacy, Tanta University, Tanta, Al-Gharbia, Egypt.
- Pharmacy Practice Department, Faculty of Pharmacy, Horus University, New Damietta, Egypt.
- Pharmacology and Biochemistry Department, Faculty of Pharmacy, Horus University, New Damietta, Egypt.
- Department of Zoology, Genetic Engineering and Molecular Biology Division, Faculty of Science, Menoufia University, Shebin El-Kom, Menoufia, Egypt.
- Biochemistry Department, Faculty of Pharmacy, Tanta University, Tanta, Al-Gharbia, Egypt.
ORCID-Profile: Mostafa M Bahaa
Förderung
- None
Zitieren
APA
Binsaleh, A. Y., Kotkata, F. A., Bahaa, M. M., Hamouda, A. O., El-Gammal, M. A., Elberri, A. I., Selim, H. M., El-Samongy, M. A., Hamouda, M. A., Mokhtar, F. A., Fahmy, S. A., Elmasri, T. A., & Elberri, E. I. (2024). Tacrolimus versus hydrocortisone in management of atopic dermatitis in children, a randomized controlled double‐blind study: New insights on TARC, CTACK, TSLP, and E‐selectin. Immunity, Inflammation and Disease. https://doi.org/10.1002/iid3.70028
Vancouver
Binsaleh AY, Kotkata FA, Bahaa MM, Hamouda AO, El-Gammal MA, Elberri AI, et al. Tacrolimus versus hydrocortisone in management of atopic dermatitis in children, a randomized controlled double‐blind study: New insights on TARC, CTACK, TSLP, and E‐selectin. Immunity, Inflammation and Disease. 2024. doi:10.1002/iid3.70028
BibTeX
@article{Binsaleh2024,
author = {Binsaleh, Ammena Y and Kotkata, Fedaa A and Bahaa, Mostafa M and Hamouda, Amir O and El-Gammal, Mohamad A and Elberri, Aya Ibrahim and Selim, Hend Mostafa and El-Samongy, Marwa Ahmed and Hamouda, Manal A and Mokhtar, Fatma A and Fahmy, Sherif Ashraf and Elmasri, Thanaa A and Elberri, Eman I},
title = {Tacrolimus versus hydrocortisone in management of atopic dermatitis in children, a randomized controlled double‐blind study: New insights on TARC, CTACK, TSLP, and E‐selectin},
journal = {Immunity, Inflammation and Disease},
year = {2024},
doi = {10.1002/iid3.70028}
}
EUVIMED